Review on anti-microbial resistance patterns of staphylococcus aureus isolated from mastitic cow's milk: Ethiopian context

Aim of this paper is to review antimicrobial resistance profile of Staphylococcus aureus (S. aureus) isolated from mastitic cow milk in Ethiopia between 2013- 2023. S. aureus causes chronic intramammary infections, causing financial losses and challenging antimicrobial therapy globally. In Ethiopia meta-analysis of the pooled prevalence of bovine mastitis was 47.6% showing S. aureus as the major isolates accounting for 13.4% and 16.5% of clinical and subclinical mastitis. In Ethiopia, there are indication of the misuse of antibiotics coupled with the rapid spread of resistant bacterial nature and inadequate surveillance, which contributed to the problem. According to this review resistance profile of S. aureus studied in Ethiopia, the bulk of tested isolates showed alarmingly high levels of resistance to widely used antimicrobial drugs for the treatment of mastitis, particularly penicillin G and tetracycline. Variuos studies warned low susceptibility of S. aureus to commonly used antimicrobials such as penicillin G and tetracycline as a great concern because this antibiotic represents the main antibiotic group recommended for staphylococcal mastitis infection in Ethiopia. If essential steps to stop the indiscriminate use of antibiotics are not implemented, the prevalence of antibiotic-resistant S. aureus could rise posing major risks to both animal and human health. Therefore, conducting regular antimicrobial sensitivity testing before treatment helps select effective antibiotics which reduce the development of resistance to commonly used antibiotics. Further studies should be conducted to detect antimicrobial resistant strains, continiuos surveillance and monitoring of S. aureus to prevent the spread of milk-borne drug-resistant strains throughout communities.